I am a biophysicist with 4 years of drug-discovery experience. At Entact, I'm excited to contribute my experience with SPR and other biophysical techniques to push forward our understanding of DUB heterobifunctionals and move programs toward the clinic.

Prior to Entact, I worked on protein-protein interaction programs at Civetta Therapeutics and on understanding modulation of RNA splicing by small molecules at Skyhawk Therapeutics. Before moving into industry, I completed my PhD in biophysics at Harvard University and undergraduate work in Chemistry and Physics at Oberlin College.

Outside of work, I enjoy spending time with my wife, daughter, and 2 cats, and getting outside whenever possible.